Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or

Insys Theraptcs Cmn (INSY) NASDAQ

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]] [[ session ]] by (BATS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]] [[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview as of [[ item.timeDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ fieldTitles[key] ]] [[ value ]] [[ value ]]
3-Month Performance
View Chart

Fundamentals

See More
  • Market Capitalization, $K 809,570
  • Shares Outstanding, K 71,600
  • Annual Sales, $ 330,800 K
  • Annual Income, $ 58,480 K
  • 36-Month Beta 0.94
  • Price/Sales 2.45
  • Price/Book 3.00

Price Performance

See More
Period Period Low Period High Performance
1-Month
10.88 +3.31%
on 11/07/16
15.06 -25.37%
on 11/10/16
+0.55 (+5.14%)
since 11/04/16
3-Month
10.01 +12.29%
on 11/03/16
16.00 -29.75%
on 09/07/16
-3.69 (-24.72%)
since 09/06/16
52-Week
10.01 +12.29%
on 11/03/16
31.22 -64.00%
on 12/15/15
-15.56 (-58.06%)
since 12/04/15

Most Recent Stories

More News
Cannabis Companies Press on in Exploding Legal Marijuana Market

CORAL SPRINGS, Florida, November 29, 2016 /PRNewswire/ --

Cannabis Companies Press on in Exploding Legal Marijuana Market

As the legal marijuana industry continues to see high levels of competition within the marketplace, Cannabis operators in the sector are executing strategies by developing innovative services and products...

Legal Cannabis Market Expects Growth

www.Financialbuzz.com - California was one of the four states where cannabis for recreational use has voted in favor, and is now legal. California is the largest market for the legal cannabis industry...

All Eyes on the Legalization of Cannabis

Today is not only a politically important day for the United States, but also a very crucial day for marijuana industries, as many states will hold referendums on the decision to legalize recreational...

Insys Therapeutics Reports Third Quarter 2016 Results

Insys Therapeutics, Inc. (NASDAQ:INSY) ("Insys" or "the Company") today announced financial results for the three-month period ended September 30, 2016.

The Growth in Cigarette Alternatives

http://www.Financialbuzz.com - Tobacco smoking is the leading cause of avoidable death in the US, and chronic exposure to tobacco smoke is related to increased incidences of cancer as well as vascular...

Insys Therapeutics to Report Third Quarter 2016 Results

Insys Therapeutics, Inc. (NASDAQ:INSY) ("Insys" or "the Company") today announced that the Company will release its financial results for the third quarter 2016 on Thursday, November 3, 2016, before the...

New Initiatives and Elections in Cannabis Legalization

The legalization of cannabis will take a leap during Election Day if California along with four other states decide to allow the use of recreational consumption. Many have fought to pass the laws for medical...

Business owners replace idealists in legal-pot movement

DENVER (AP) — Business owners are replacing idealists in the pot-legalization movement as the nascent marijuana industry creates a broad base of new donors, many of them entrepreneurs willing to spend...

Research Reports Coverage on Biotech Stocks -- Immunomedics, ImmunoGen, INSYS Therapeutics, and Jazz Pharma

Next month's U.S. election results are once again triggering concerns over tighter drug pricing regulations should Democrats take control of Congress. On Tuesday, October 11, 2016, the $7.6 billion iShares...

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 56% Sell with a Weakest short term outlook on maintaining the current direction.

Longer term, the trend strength is Average. Long term indicators fully support a continuation of the trend.

The market is in highly oversold territory. Beware of a trend reversal.

See More

Business Summary

Insys Therapeutics, Inc. is a commercial-stage specialty pharmaceutical company. It is engaged in the development and commercialization of pharmaceutical products that target the unmet needs of cancer patients, with an initial focus on cancer-supportive care. The company's cancer-supportive care and...

See More

Support & Resistance

2nd Resistance Point 11.70
1st Resistance Point 11.47
Last Price 11.24
1st Support Level 10.96
2nd Support Level 10.68

See More

Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.